MetLife Investment Management LLC Boosts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

MetLife Investment Management LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 109,802 shares of the medical equipment provider’s stock after purchasing an additional 1,500 shares during the quarter. MetLife Investment Management LLC’s holdings in Intuitive Surgical were worth $57,312,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Natixis boosted its holdings in shares of Intuitive Surgical by 0.9% in the fourth quarter. Natixis now owns 50,557 shares of the medical equipment provider’s stock valued at $26,389,000 after purchasing an additional 463 shares during the period. Norinchukin Bank The raised its position in Intuitive Surgical by 6.2% during the 4th quarter. Norinchukin Bank The now owns 21,566 shares of the medical equipment provider’s stock valued at $11,257,000 after purchasing an additional 1,259 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S raised its position in Intuitive Surgical by 71.1% during the 4th quarter. BI Asset Management Fondsmaeglerselskab A S now owns 38,537 shares of the medical equipment provider’s stock valued at $20,115,000 after purchasing an additional 16,020 shares in the last quarter. Capital Research Global Investors lifted its holdings in shares of Intuitive Surgical by 25.5% in the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider’s stock worth $1,764,904,000 after buying an additional 687,906 shares during the period. Finally, Elevatus Welath Management grew its position in shares of Intuitive Surgical by 2.7% during the 4th quarter. Elevatus Welath Management now owns 8,412 shares of the medical equipment provider’s stock worth $4,391,000 after buying an additional 223 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock worth $17,691,621 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $482.74 on Friday. The company has a market capitalization of $171.94 billion, a price-to-earnings ratio of 75.31, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a 50-day simple moving average of $522.23 and a 200-day simple moving average of $532.02.

Analyst Ratings Changes

Several analysts recently weighed in on ISRG shares. Leerink Partners lifted their price objective on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Robert W. Baird dropped their target price on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 18th. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a “buy” rating in a research note on Monday. Finally, Jefferies Financial Group raised their price objective on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $611.81.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.